Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pharmacogenomic Study in Myeloma Patients Treated With Melphalan-prednisone-thalidomide or Lenalidomide-dexamethasone

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2011 by Intergroupe Francophone du Myelome.
Recruitment status was  Active, not recruiting
Information provided by:
Intergroupe Francophone du Myelome Identifier:
First received: May 20, 2009
Last updated: June 18, 2011
Last verified: June 2011
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: September 2011 (Final data collection date for primary outcome measure)